asset manager
Mission BioCapital
CAMBRIDGE, MA
CRD: 319585
In network coverage since October 8, 2026 · 4 stories
Regulatory AUMSEC Form ADV · Oct 24
4Deals on our tracker
Regulatory AUM · Oct 10 – Oct 24
Deal recordFull tracker →
Sep 28, 26Deal closedLjungström family office · Breye Therapeutics · Novo Holdings · $68
Network coverage
Direct & Co-Investments
Ljungström family office co-led AnaCardio AB's €62.5 million Series B, joined Breye Series A
The AnaCardio financing is earmarked to fund a Phase 2b trial of AC01 in about 400 patients across twelve countries.